Dupilumab-Improved Lung Function Lasts in Children With Asthma Dupilumab-Improved Lung Function Lasts in Children With Asthma

Add-on treatment with dupilumab may improve lung function in children aged 6-11 years with uncontrolled moderate to severe type 2 inflammatory asthma, results from a phase 3 study show.Medscape Medical News

Source: Medscape Medical News Headlines - October 18, 2021 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news